Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis? [PDF]
Maria B. Grant+5 more
openalex +1 more source
Time course of restenosis during the first year after emergency coronary stenting. [PDF]
Adnan Kastrati+4 more
openalex +1 more source
Stent-induced hypersensitivity leading to refractory in-stent restenosis: a case report
Background Even in the era of new-generation drug-eluting stents, in-stent restenosis remains a common and challenging problem of percutaneous coronary intervention.
Menghuai Ma, Jiong Tang
doaj +1 more source
Development of coronary stents using advanced results of materials science and technology [PDF]
Stents are high tech endovascular implants. K&M Inc. is the single Eastern European stent producer company. The market needs more biocompatible devices as the trend of the stent development all the producers have to react.
Dobránszky, János+3 more
core
Restenosis after directional coronary atherectomy. Effects of luminal diameter and deep wall excision. [PDF]
Richard E. Kuntz+5 more
openalex +1 more source
IV-11 The results of operation for mitral restenosis subsequent to mitral commissurotomy
本田 剛彦+5 more
openalex +2 more sources
Functional health status in male patients without restenosis following successful ptca [PDF]
Damian Franzen+5 more
openalex +1 more source